THYROCAREBSEThyrocare Technologies LtdMediumNeutral
Announced Sat, 25 Apr · 10:36 IST

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 20, 2026 for Docon Technologies Pvt Ltd

Ownership Changes View source PDF

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.2%1-day move
₹394.05
prior close
₹395.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.8+0.7+0.7+2.3+3.2+3.7+1.5+6.8+9.9+19.9+19.1+29.2+33.3+48.0
Up moveDown movePending
AI summary

BSE received a disclosure under SEBI SAST Regulations 31(1) and 31(2) from Docon Technologies Pvt Ltd on April 20, 2026. However, the actual document content was not accessible as BSE returned an error page stating the page had been moved. Regulation 31 typically relates to disclosure of encumbrances on promoter shares. Without the actual filing details, the nature of the transaction—whether it involves pledge creation, release, or acquisition—cannot be determined from the available information.

Likely market impact

Unable to assess shareholder impact as the detailed transaction information was not available in the filing.